Use of Johnson & Johnson's Covid-19 vaccine should resume, U.S. health regulators said. The shots could be back in circulation as soon as this weekend. on.wsj.com
@variety.com4 years ago
Markets Rally on Promising Vaccine Report and Biden Win, Theater and Theme Park Shares Soar
@WSJ4 years ago
Johnson & Johnson bet big on a new vaccine technology a decade ago. It paid off this weekend with U.S. approval of its Covid-19 shot. Here's how they did it. on.wsj.com
@cbsnews.com5 years ago
House passes $3 trillion coronavirus stimulus bill opposed by Trump
@forbes.com4 years ago
Doctors Hail Transparency In FDA And CDC Vaccine Authorizations
@snopes.com4 years ago
Moderna Asking US, European Regulators to OK Its Virus Shots
